
Breast Cyst Treatment Market to Hit $1.84Bn by 2031, Boosted by Imaging Tech and Rising Awareness | DataM Intelligence

Breast Cyst Treatment Market
Breast cyst treatment market set to grow from $1.2Bn in 2024 to $1.84Bn by 2031, fueled by diagnostics and global awareness.
NEW YORK, NY, UNITED STATES, May 28, 2025 /EINPresswire.com/ -- Market Overview
The Breast Cyst Treatment Market is gaining momentum, propelled by greater health awareness, diagnostic improvements, and access to non-invasive treatment. Valued at USD 1.2 billion in 2024, the market is expected to reach USD 1.84 billion by 2031, growing at a CAGR of 6.3% during the forecast period. As benign breast conditions like cysts become more commonly diagnosed especially among women over 35.the need for accessible and effective treatment options is more urgent than ever.
Market Drivers
Rising prevalence of benign breast cysts, particularly in women aged 35 to 50.
Technological improvements in imaging (ultrasound, MRI, digital mammography) enhancing detection accuracy.
Greater health education and screening programs encouraging early visits and proactive care.
Minimally invasive procedures, like fine-needle aspiration, are preferred for faster recovery and reduced hospital stays.
Growing financial support for women’s health initiatives, particularly in developing regions.
Shift to outpatient care and ambulatory diagnostics, reducing overall treatment costs.
Get Free Premium Sample Report: https://www.datamintelligence.com/download-sample/breast-cyst-treatment-market
Market Key Players
Leading players in the breast cyst treatment landscape are innovating in imaging, diagnostics, and therapeutic devices. Notable companies include:
Advin Health Care
Argon Medical Devices, Inc.
Becton, Dickinson, and Company
BPB MEDICA
HAKKO CO., LTD.
Remington Medical Inc.
SOMATEX Medical Technologies GmbH
Swastik Enterprise
These organizations are focusing on AI-integrated imaging tools, better hormone-based therapies, and expanding their diagnostic infrastructure globally.
Market Segmentation
By Type:
Simple Breast Cysts
Complex Breast Cysts
Complicated Breast Cysts
By Diagnosis Method:
Mammography
Ultrasound
Fine-Needle Aspiration (FNA)
Magnetic Resonance Imaging (MRI)
By Treatment Type:
Watchful Monitoring
Aspiration/Drainage
Hormonal Therapy
Surgical Removal (in rare or complex cases)
By End User:
Hospitals
Diagnostic Centers
Ambulatory Surgical Units
Specialized Women’s Clinics
Latest News of USA
Jan 2024: GE Healthcare released a next-gen AI-based ultrasound system to improve cyst identification accuracy.
Mar 2024: The American Cancer Society expanded its national breast health campaign to include awareness about benign conditions like cysts.
Jun 2024: FDA approved a novel hormone therapy designed to relieve recurring pain from complex breast cysts.
Aug 2024: Philips updated its mammography platform with enhanced features specifically to detect non-cancerous cyst formations.
Latest News of Japan
Feb 2024: Tokyo Women’s Medical University launched a study on AI-enhanced ultrasound scans for early cyst identification with 95% success.
Apr 2024: Japan’s Ministry of Health included breast cyst checks in routine health screenings for women aged 35 and older.
Jul 2024: Hitachi Medical introduced a portable, hand-held breast scanner aimed at improving rural access to diagnostic services.
Oct 2024: Takeda Pharmaceuticals announced R&D investment in imaging solutions for breast conditions including cystic abnormalities.
Key Developments
Jan 2024: GE Healthcare introduced AI-enabled breast ultrasound for accurate cyst analysis.
Feb 2024: Osaka University launched clinical trials for AI-based cyst detection using ultrasound.
Apr 2024: FDA approved a novel hormone therapy specifically targeting complex cyst symptoms.
May 2024: Philips rolled out upgraded mammography tech with enhanced cyst detection capabilities.
Aug 2024: Roche began clinical studies for new treatments aimed at managing recurring cysts.
Nov 2024: Japan revised breast screening
Conclusion
The breast cyst treatment market is poised for strong growth, driven by early detection, cutting-edge imaging, and minimally invasive procedures. Worldwide initiatives to boost awareness and accessibility especially in the U.S. and Japan are making the market more inclusive and efficient. Leading companies are focusing on technologies that emphasize safety, speed, and precision, shaping the future of breast cyst diagnosis and care globally. With healthcare moving toward patient-centered and preventive approaches, the market outlook is optimistic and forward looking.
Related Reports :
Breast Cancer Treatment Market Size 2025-2033
Global Thyroid Cancer Treatment Market -Forecast (2025-2033)
Sai Kumar
DataM Intelligence 4market Research LLP
+1 877-441-4866
email us here
Visit us on social media:
LinkedIn
X

Distribution channels: Healthcare & Pharmaceuticals Industry
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Submit your press release